Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Experts Warn Of Dangers In Australia's Mass H1N1 Flu Vaccination Plan

This article was originally published in PharmAsia News

Executive Summary

Some Australian infectious-disease experts urged the government to cancel a plan to vaccinate as many people as possible against the H1N1 flu. They warned of a contamination risk that could spread blood-borne diseases. The Australasian Society for Infectious Disease sent a letter to the Health Ministry saying the risk lies in multi-dose vials for the vaccine supplied by CSL. The organization urged a delay in the mass-vaccination plan until the vaccine can be issued with single-dose vials. The letter said the medical community already knows multi-dose vials often transmit infectious diseases, some resulting in death. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel